title: Alfa 1 adrenergic potentiation of progesterone accumulation stimulated by vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in cultured rat granulosa cells.
abstract: OBJECTIVE
  VIP and PACAP, two structurally related peptides, stimulate c AMP, steroidogenesis and progesterone (PROG) release from cultured rat granulosa cells. VIP and PACAP(38) are known to mimic the effects of beta-adrenergic receptor stimulation in the rat pinealocytes causing an increased melatonin synthesis. These effects were markedly potentiated by alpha(1) adrenergic receptor stimulation.
  
  
  METHODS
  We examined the influence of phenylonephrine (PHEN) (10(-4) M and 10(-5) M)-alpha(1) adrenergic receptor agonist and fenoterol (FEN) (10(-5) M)-beta(2) adrenergic receptor agonist on PROG accumulation stimulated by VIP (10(-6) M) and PACAP (10(-7) M) in cultured ovarian granulosa cells of cyclic rats (diestrus) after 2 h and 24 h incubation. The PROG concentrations in supernatants were measured with RIA tests.
  
  
  RESULTS
  VIP, PACAP(38), PHEN and FEN stimulated PROG accumulation after 2 h incubation. The PROG accumulation stimulated both by FEN and VIP, and by FEN and PACAP(38) was not additive. PROG accumulation stimulated by VIP and PACAP(38) was strongly potentiated by PHEN-alpha(1) adrenergic agonist.
  
  
  CONCLUSIONS
  The alpha(1) adrenergic potentiation of VIP and PACAP(38) stimulatory effects on PROG release from granulosa cells culture was found. VIP, PACAP(38) and beta(2) adrenergic receptors activation may share the same postreceptor mechanism. There exists simultaneous activation of different receptors -- peptidergic and adrenergic ones in cultured granulosa cells of adult cyclic rat.
authors.affiliation: Department of Clinical Neuroendocrinology Medical Centre of Postgraduate Education, 04-158 Warsaw, Poland. zncmkp@free.polbox.pl
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Wasilewska-Dziubiñska
authors.forename: Monika
authors.initials: M
authors.lastname: Borowiec
authors.forename: Magdalena
authors.initials: M
authors.lastname: Chmielowska
authors.forename: Ewa
authors.initials: E
authors.lastname: Woliñska-Witort
authors.forename: Boguslawa
authors.initials: B
authors.lastname: Baranowska
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D004357:Drug Synergism; D005260:Female; D005280:Fenoterol / Q000494:pharmacology; D006107:Granulosa Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009479:Neuropeptides / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011374:Progesterone / Q000378:metabolism*; D051381:Rats; D011921:Rats, Inbred WKY; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: C495403:Adcyap1 protein, rat; D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D010656:Phenylephrine; D005280:Fenoterol; D014660:Vasoactive Intestinal Peptide; D011374:Progesterone